Literature DB >> 1125624

Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.

R C Bucknall, J Dixon A St, E N Glick, J Woodland, D W Zutshi.   

Abstract

Four patients with rheumatoid arthritis (R.A.) developed myasthenia gravis after taking penicillamine. In one patient withdrawal of the drug was followed by spontaneous remission of the myasthenia, and in two the dose of anticholinesterase was subsequently reduced. In the fourth patient continuing penicillamine treatment was associated with increasingly severe myasthenic features, but on withdrawal of the drug these resolved. As myasthenia gravis rarely complicates R.A. its onset in these patients shortly after the start of penicillamine treatment suggested that penicillamine may have precipitated this condition.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1125624      PMCID: PMC1672801          DOI: 10.1136/bmj.1.5958.600

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

Review 1.  SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

Authors:  K J BLOCH; W W BUCHANAN; M J WOHL; J J BUNIM
Journal:  Medicine (Baltimore)       Date:  1965-05       Impact factor: 1.889

2.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

3.  Antibiotic-induced neuromuscular blockade.

Authors:  E A Wright; M P McQuillen
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

4.  Curare sensitivity and myastheniform symptoms in patients with rheumatoid arthritis.

Authors:  H J Oosterhuis; W H de Haas
Journal:  Acta Rheumatol Scand       Date:  1969

5.  Rheumatic diseases in patients with myasthenia gravis. An epidemiological and clinical investigation.

Authors:  H J Oosterhuis; W H de Haas
Journal:  Acta Neurol Scand       Date:  1968       Impact factor: 3.209

Review 6.  Myasthenia gravis as an autoimmune disease: clinical aspects.

Authors:  J A Simpson
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

  6 in total
  26 in total

1.  Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

Authors:  R C Bucknall
Journal:  Proc R Soc Med       Date:  1977

Review 2.  Penicillamine types in the sclerodermas.

Authors:  T H Tio
Journal:  Proc R Soc Med       Date:  1977

Review 3.  Myasthenic crisis.

Authors:  David Lacomis
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Clinical significance of antibodies to native DNA as measured by a DNA binding technique in patients with articular features of rheumatoid arthritis.

Authors:  D M Grennan; D Sloane; A Behan; W C Dick
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

5.  Penicillamine in the treatment of rheumatoid arthritis.

Authors:  A V Camp
Journal:  Proc R Soc Med       Date:  1977-02

6.  Pemphigus erythematosus-like rash in a patient on penicillamine.

Authors:  O Scherak; G Kolarz; K Molubar
Journal:  Br Med J       Date:  1977-03-26

Review 7.  Pathogenesis and treatment of myasthenia gravis.

Authors:  G K Scadding; C W Havard
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-17

8.  Cholestatic jaundice caused by D-penicillamine.

Authors:  D Barzilai; G Dickstein; R Enat; H Bassan; C Lichtig; B Gellei
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

9.  [Myasthenic syndrome during penicillamine treatment (author's transl)].

Authors:  F Schumm; M Stöhr
Journal:  Klin Wochenschr       Date:  1978-02-01

10.  Anti-acetylcholine receptor antibodies.

Authors:  A Vincent; J Newsom Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.